Literature DB >> 17389751

Improved outcomes from acute severe asthma in Australian intensive care units (1996 2003).

Peter J Stow1, David Pilcher, John Wilson, Carol George, Michael Bailey, Tracey Higlett, Rinaldo Bellomo, Graeme K Hart.   

Abstract

BACKGROUND: There is limited information on changes in the epidemiology and outcome of patients with asthma admitted to intensive care units (ICUs) in the last decade. A database sampling intensive care activity in hospitals throughout Australia offers the opportunity to examine these changes.
METHODS: The Australian and New Zealand Intensive Care Society Adult Patient Database was examined for all patients with asthma admitted to ICUs from 1996 to 2003. Demographic, physiological and outcome information was obtained and analysed from 22 hospitals which had submitted data continuously over this period.
RESULTS: ICU admissions with the primary diagnosis of asthma represented 1899 (1.5%) of 126 906 admissions during the 8-year period. 36.1% received mechanical ventilation during the first 24 h. The overall incidence of admission to ICU fell from 1.9% in 1996 to 1.1% in 2003 (p<0.001). Overall hospital mortality was 3.2%. There was a significant decline in mortality from a peak of 4.7% in 1997 to 1.1% in 2003 (p = 0.014). This was despite increasing severity of illness (as evidenced by an increasing predicted risk of death derived from the APACHE II score) over the 8-year period (p = 0.002).
CONCLUSIONS: There has been a significant decline in the incidence of asthma requiring ICU admission between 1996 and 2003 among units sampled by the Australian and New Zealand Intensive Care Society Adult Patient Database. The mortality of these patients has also decreased over time and is lower than reported in other studies.

Entities:  

Mesh:

Year:  2007        PMID: 17389751      PMCID: PMC2094264          DOI: 10.1136/thx.2006.075317

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Clinical course and outcome of patients admitted to an ICU for status asthmaticus.

Authors:  B Afessa; I Morales; J D Cury
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

2.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.

Authors:  P K Plant; J L Owen; M W Elliott
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

3.  Surveillance for asthma--United States, 1980-1999.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Jeanne E Moorman; Charon Gwynn; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-03-29

4.  The burden of asthma in Australia.

Authors:  A J Woolcock; S A Bastiampillai; G B Marks; V A Keena
Journal:  Med J Aust       Date:  2001-08-06       Impact factor: 7.738

5.  Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980-1997.

Authors:  H J Zar; D Stickells; A Toerien; D Wilson; M Klein; E D Bateman
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

6.  IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.

Authors:  Robert A Silverman; Harold Osborn; Jeffrey Runge; E John Gallagher; William Chiang; James Feldman; Theodore Gaeta; Katherine Freeman; Bruce Levin; Noel Mancherje; Steven Scharf
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

7.  Trends of asthma in Mexico: an 11-year analysis in a nationwide institution.

Authors:  Mario H Vargas; Guillermo S Díaz-Mejía; María E Y Furuya; Jorge Salas; Alejandro Lugo
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

8.  Continuing decreases in asthma mortality in the United States.

Authors:  R Michael Sly
Journal:  Ann Allergy Asthma Immunol       Date:  2004-03       Impact factor: 6.347

Review 9.  Acute severe asthma.

Authors:  E R McFadden
Journal:  Am J Respir Crit Care Med       Date:  2003-10-01       Impact factor: 21.405

10.  Characteristics and outcome for admissions to adult, general critical care units with acute severe asthma: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Dheeraj Gupta; Brian Keogh; Kian Fan Chung; Jon G Ayres; David A Harrison; Caroline Goldfrad; Anthony R Brady; Kathy Rowan
Journal:  Crit Care       Date:  2004-03-03       Impact factor: 9.097

View more
  6 in total

1.  Ten years of asthma admissions to adult critical care units in England and Wales.

Authors:  Ben Gibbison; Kathryn Griggs; Mome Mukherjee; Aziz Sheikh
Journal:  BMJ Open       Date:  2013-09-19       Impact factor: 2.692

2.  Factors for poor prognosis of near-fatal asthma after recovery from a life-threatening asthma attack.

Authors:  Myung Shin Kim; Young Joo Cho; Hee Bom Moon; Sang Heon Cho
Journal:  Korean J Intern Med       Date:  2008-12       Impact factor: 2.884

3.  Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study.

Authors:  Pierrick Bedouch; Mohsen Sadatsafavi; Carlo A Marra; J Mark FitzGerald; Larry D Lynd
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

4.  Hospitalization rate and 30-day mortality among patients with status asthmaticus in Denmark: a 16-year nationwide population-based cohort study.

Authors:  Jennie Maria Christin Strid; Henrik Gammelager; Martin Berg Johansen; Else Tønnesen; Christian Fynbo Christiansen
Journal:  Clin Epidemiol       Date:  2013-09-05       Impact factor: 4.790

5.  Asthma changes at a pediatric intensive care unit after 10 years: Observational study.

Authors:  Ayman A Al-Eyadhy; Mohamad-Hani Temsah; Ali A N Alhaboob; Abdulmalik K Aldubayan; Nasser A Almousa; Abdulrahman M Alsharidah; Mohammed I Alangari; Abdulrahman M Alshaya
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

Review 6.  Hypercapnia: An Aggravating Factor in Asthma.

Authors:  Masahiko Shigemura; Tetsuya Homma; Jacob I Sznajder
Journal:  J Clin Med       Date:  2020-10-05       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.